Animal study · mice

KPV reduced white blood cell buildup in mice with peritonitis

Checked against the paper Animal studyPublished by PepVault

The takeaway

In mice, KPV calmed belly inflammation in a different way from the larger MSH peptides, and the authors think it does not work through melanocortin receptors.

Kind
Animal study
Studied in
Mice
Published
2003
Journal
J Pharmacol Exp Ther

What they tested

The team tested how KPV, a 3-part piece of the hormone alpha-MSH, compares with other MSH peptides at calming inflammation, and whether it works through melanocortin receptors.

How the study was done

A mouse study using crystal-induced peritonitis (inflammation of the belly lining), plus cell tests on macrophages, a type of immune cell. KPV was compared with alpha-MSH, the core peptide His-Phe-Arg-Trp, the receptor 3/4 activator MTII and the MC1 receptor activator MS05.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking KPV? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

In mice, KPV, alpha-MSH, His-Phe-Arg-Trp and MTII given systemically all significantly reduced the buildup of polymorphonuclear leukocytes in the belly cavity, while MS05 did not. SHU9119, a drug that blocks melanocortin receptors 3 and 4, did not stop KPV's effect. In cell tests on macrophages, alpha-MSH and MTII lowered the release of the signals KC and IL-1beta, but KPV did not, and KPV also did not raise cAMP, a messenger inside cells. In mice, KPV still reduced inflammation in IL-1beta-induced peritonitis and in mice whose MC1 receptor does not work.

What it doesn’t show

This is mouse and cell work in belly inflammation models, so it is not a human result. The idea that KPV acts by blocking IL-1beta functions is the authors' proposed explanation, not something they directly showed.

The paper

Getting et al. Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides. J Pharmacol Exp Ther. 2003.

The compound

More studies on KPV

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking KPV? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo